These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27340747)

  • 1. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
    Bartosch C; Pires-Luís AS; Meireles C; Baptista M; Gouveia A; Pinto C; Shannon KM; Jerónimo C; Teixeira MR; Lopes JM; Oliva E
    Am J Surg Pathol; 2016 Sep; 40(9):1177-91. PubMed ID: 27340747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome.
    Karamurzin Y; Soslow RA; Garg K
    Am J Surg Pathol; 2013 Apr; 37(4):579-85. PubMed ID: 23426126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
    Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
    Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
    Fedda FA; Euscher ED; Ramalingam P; Malpica A
    Int J Gynecol Pathol; 2020 Jul; 39(4):313-320. PubMed ID: 31851061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.
    Niskakoski A; Pasanen A; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B
    J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.
    Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
    Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
    Broaddus RR; Lynch HT; Chen LM; Daniels MS; Conrad P; Munsell MF; White KG; Luthra R; Lu KH
    Cancer; 2006 Jan; 106(1):87-94. PubMed ID: 16323174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas.
    Niskakoski A; Pasanen A; Porkka N; Eldfors S; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Gynecol Oncol; 2018 Jul; 150(1):92-98. PubMed ID: 29716739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.
    Downes MR; Allo G; McCluggage WG; Sy K; Ferguson SE; Aronson M; Pollett A; Gallinger S; Bilbily E; Shaw P; Clarke BA
    Histopathology; 2014 Aug; 65(2):228-39. PubMed ID: 24495259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
    Chapel DB; Yamada SD; Cowan M; Lastra RR
    Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome.
    Wadee R; Grayson W
    Ann Diagn Pathol; 2019 Apr; 39():92-104. PubMed ID: 30798077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
    Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.